July 30, 2019
Weil advised Willis Towers Watson in $1.3 billion acquisition of TRANZACT. Willis Towers Watson is a global advisory, broking and solutions company and TRANZACT is a direct-to-consumer health care organization that links individuals to U.S. insurance carriers. TRANZACT will operate as an integral part of Willis Towers Watson’s Benefits Delivery and Administration business, which focuses on the development and delivery of administrative solutions for employers, employees and retirees.
Weil previously advised Willis Group Holdings in its $18 billion merger with Towers Watson & Co. in 2015.
The Weil team was led by Mergers & Acquisitions partner Michael Aiello and included Mergers & Acquisitions partner Jackie Cohen and Mergers & Acquisitions associates Rachel Shapiro, Rob Cohen, Joseph Godio, Alex Chelesnik and Michael Chenkin. The team also included Co-Chair of Tax Joe Pari and Tax partner Devon Bodoh; Head of Executive Compensation & Benefits Paul Wessel; Structured Finance & Derivatives partner Shawn Kodes; Technology & IP Transactions Head Michael Epstein; Banking & Finance partner Courtney Marcus; Real Estate partner David Herman; Regulatory partner Ted Posner; Antitrust/Competition partner Jeffrey Perry; Labor and Employment partner Nicholas Pappas; Co-Head of Cybersecurity, Data Privacy & Information Management Randi Singer; Insurance counsel Gabriel Gershowitz and Thomas Goslin; Antitrust/Competition counsel Vadim Brusser; Tax associates Eric Remijan, Soo Jin Kim and Sidney Chiang; Executive Compensation & Benefits associates Akansha Mishra and Lauren Sawyer (Not Yet Admitted in New York); Structured Finance & Derivatives associate Matthew Nemeth; Technology & IP Transactions associate Maryann Thompson; Banking & Finance associates Vynessa Nemunaitis and Veronica Bonhamgregory; Real Estate associate Joseph Sadon; Antitrust/Competition associate Natalie Hayes; Employment Litigation associate Justin DiGennaro; and Cybersecurity, Data Privacy & Information Management associate Elisabeth Sperle.